For the 22 patients diagnosed with Coenzyme Q10 (CoQ10) deficiency-associated glomerulopathy caused by the pathogenic variants of COQ8B, oral supplementation with CoQ10 should be continued following transplantation. The gene discussed is AGO2; the disease is coenzyme Q10 deficiency.